Board to approve Novartis India’s unaudited Q3 FY2025 results for the quarter ended December 31, 2025; trading window closes Jan 1, 2026 and reopens 48 hours after results.
AI Assistant
Novartis India Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.